He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

Microcap Allurion Technologies (NYSE:ALUR) surged ~31% in after-hours trading Thursday after posting preliminary data on ...

Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest ...

India's obesity crisis is intensifying, with big pharma companies like Eli Lilly and Novo Nordisk competing to introduce ...

Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

Wegovy) had a twofold higher risk of hair loss than those starting on the weight-loss drug bupropion-naltrexone (Contrave): All patients: adjusted HR 1.52 (95% CI 0.86-2.69) Men: adjusted HR 0.86 ...

The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...